documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
19 rows where docket_id = "NRC-2022-0218" and posted_year = 2024 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_date, posted_month, last_modified, withdrawn, posted_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRC-2022-0218-0190 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | 07-10-24 Ron Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Information Correction Request submitted to NRC in February 2023, and the most recent NRC OIG findings | Supporting & Related Material | 2024-09-30T00:00:00Z | 2024 | 9 | 2025-05-21T06:22:01Z | 0 | 0 | 09000064867a2e8b | ||||
| NRC-2022-0218-0191 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | 08-27-24 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: NRC's reply and the proposed rule regarding the reporting of extravasations | Supporting & Related Material | 2024-09-30T00:00:00Z | 2024 | 9 | 2025-05-21T06:22:01Z | 0 | 0 | 09000064867a2e8d | ||||
| NRC-2022-0218-0189 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | April 11, 2023 - NRC Response to Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter regarding Extravasation, Abnormal Occurrence reporting, and Information Correction Requests | Supporting & Related Material | 2024-09-25T00:00:00Z | 2024 | 9 | 2025-05-21T06:22:02Z | 0 | 0 | 0900006486786688 | ||||
| NRC-2022-0218-0188 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 28, 2023 - Response to Ronald Lattanze Appeal Letter to the NRC Information Quality Coordinator dated May 12, 2023 re: SECY-22-0043, “Petition for Rulemaking and Rulemaking Plan on Reporting Nuclear Medicine Injection Extravasations as Medical Events" | Supporting & Related Material | 2024-09-25T00:00:00Z | 2024 | 9 | 2025-05-21T06:22:02Z | 0 | 0 | 09000064867846bb | ||||
| NRC-2022-0218-0187 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | August 8, 2024 - NRC Response to R. Lattanze July 2024 Letter | Supporting & Related Material | 2024-09-25T00:00:00Z | 2024 | 9 | 2025-05-21T06:22:02Z | 0 | 0 | 09000064867846b9 | ||||
| NRC-2022-0218-0185 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | August 7, 2024 - Letter to NRC medical staff re proposed rule and 99mTC case report | Supporting & Related Material | 2024-08-25T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:12Z | 0 | 0 | 090000648667632d | ||||
| NRC-2022-0218-0184 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | April 4, 2023 - LTR-23-0081 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Information Correction Request Follow-up | Supporting & Related Material | 2024-08-25T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:12Z | 0 | 0 | 0900006486672f5e | ||||
| NRC-2022-0218-0186 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | July 1, 2024 Email to Raymond Furstenau from Teen Cancer America and K. Williams Response Regarding Extravasations rulemaking | Supporting & Related Material | 2024-08-25T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:12Z | 0 | 0 | 090000648667632e | ||||
| NRC-2022-0218-0182 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 15, 2023 - LTR-23-0157 - Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, Letter re: Extravasations, Abnormal Occurrence reporting, and Information Correction Request | Supporting & Related Material | 2024-08-23T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:12Z | 0 | 0 | 0900006486672ea7 | ||||
| NRC-2022-0218-0183 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | February 15, 2024 - LTR-24-0030 Mary Ajango, Spokesperson, Patients for Safer Nuclear Medicine Coalition, Letter re: concerns about reporting requirements for extravasations ML24051A042 | Supporting & Related Material | 2024-08-23T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:12Z | 0 | 0 | 0900006486674c6a | ||||
| NRC-2022-0218-0173 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | Draft for ACMUI Review - Draft Model Procedures for Evaluating and Reporting Extravasation Medical Events | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665e6b5 | ||||
| NRC-2022-0218-0176 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 11, 2024 - Draft Report - Subcommittee on Extravasations | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665e6f3 | ||||
| NRC-2022-0218-0180 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | February 16, 2023 - LTR-23-0038 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Extravasation, Abnormal Occurrence Reporting, and Information Correction Requests | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 1 | 090000648665e7ce | ||||
| NRC-2022-0218-0174 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 17, 2024 - MUI Extravasations Meeting Handout | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665e6b8 | ||||
| NRC-2022-0218-0175 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | August 21, 2024 - For ACMUI Review - Preliminary Extravasation Proposed Rule Package | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665e6bb | ||||
| NRC-2022-0218-0178 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 17, 2024 - Transcript of Meeting of the Advisory Committee on the Medical Uses of Isotopes - Pages 1 - 93 | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665ec26 | ||||
| NRC-2022-0218-0181 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | May 12, 2023 LTR-23-0129 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Abnormal Occurrence Reporting, and Information Correction Request | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 09000064866601ee | ||||
| NRC-2022-0218-0179 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | NRC Response to Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC - Letter regarding Extravasation. Abnormal Occurrence Reporting and Information Correction Requests | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665ed18 | ||||
| NRC-2022-0218-0177 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 17, 2024 - Final Report - Advisory Committee on Medical Uses of Isotopes (ACMUI) | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665e6f2 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;